MEDI-563, a humanized anti–IL-5 receptor α mAb with enhanced antibody-dependent cell-mediated cytotoxicity functionRoland Kolbeck, Anthony J. Coyle, Leif Bjermer et al.|Journal of Allergy and Clinical Immunology|2010Cited by 578
A Phase 2, Randomized, Double-blind, Placebo-Controlled Trial of Presatovir for the Treatment of Respiratory Syncytial Virus Upper Respiratory Tract Infection in Hematopoietic-Cell Transplant RecipientsRoy F. Chemaly, Michael Boeckh, Polina German et al.|Clinical Infectious Diseases|2019Cited by 75